Akathisia as a side effect of medicinal products;Acathisie als bijwerking van geneesmiddelen

Nederlands Tijdschrift voor Geneeskunde

Volumn 146, Issue 3, 2002, Pages 110-114

  Van Harten, P N ^a  

^a Symfora Groep   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; HERBACEOUS AGENT; MIANSERIN; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE;

AGITATION; AKATHISIA; ANTICHOLINERGIC EFFECT; ARTICLE; EXTRAPYRAMIDAL SYMPTOM; HUMAN; MENTAL DISEASE; PATIENT COMPLIANCE; RESTLESS LEGS SYNDROME; SIDE EFFECT;

AKATHISIA, DRUG-INDUCED; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CLOZAPINE; DIABETES COMPLICATIONS; DIAGNOSIS, DIFFERENTIAL; DIBENZOTHIAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; PIRENZEPINE; PREVALENCE; PSYCHOMOTOR AGITATION; RECURRENCE; RESTLESS LEGS SYNDROME; RISK FACTORS;

EID: 0037132794     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders
2. Why do schizophrenic patients refuse to take their drugs?
3. Subjective experience of treatment, side-effects, mental state and quality of life in chronic schizophrenic out-patients treated with depot neuroleptics
4. Clinical characteristics and predisposing factors in acute drug-induced akathisia
5. Response to antipsychotic medication: The doctor's and the consumer's view
6. A survey of drug-induced extrapyramidal reactions
7. Clinical characteristics of akathisia. A systematic investigation of acute psychiatric inpatient admissions
8. The epidemiology of drug-induced akathisia. Part I. Acute akathisia
9. Painful sensory symptoms in neuroleptic-induced extrapyramidal syndromes
10. The present status of tardive dyskinesia and akathisia in the treatment of schizophrenia
11. A rating scale for drug-induced akathisia
12. Akathisia variants and tardive dyskinesia
13. Reliability and applicability of movement disorder rating scales in the elderly
14. A polysomnographic study on periodic limb movements in patients with restless legs syndrome and neuroleptic-induced akathisia
15. The effect of activation procedures on neuroleptic-induced akathisia
16. The epidemiology of drug-induced akathisia. Part II. Chronic, tardive, and withdrawal akathisias
17. Akathisia in Parkinson's disease
18. Akathisia
19. Acathisie, een literatuuroverzicht
20. Placebo-controlled study of the D4/5-HT2A antagonist fananserin in the treatment of schizophrenia
21. Atypische antipsychotica en de kans op extrapiramidale bijwerkingen
22. Propranolol attenuates haloperidol-induced Fos expression in discrete regions of rat brain: Possible brain regions responsible for akathisia
23. Beta 2-receptor density on mononuclear blood cells in patients suffering from neuroleptic-induced akathisia (NIA)
24. Association of dopamine D3-receptor gene variants with neuroleptic induced akathisia in schizophrenic patients: A generalization of Steen's study on DRD3 and tardive dyskinesia
25. SSRI-induced extrapyramidal side-effects and akathisia: Implications for treatment
26. Akathisia and acute dystonia induced by sumatriptan
27. Extrapyramidal symptoms during long-term treatment with antipsychotics special focus on clozapine and D1 and D2 dopamine antagonists
28. Neurologic side effects in neurolepticnaive patients treated with haloperidol or risperidone
29. Risperidone in the treatment of first-episode psychotic patients: A double-blind multicenter study
30. Use of neuroleptic-induced extrapyramidal symptoms to predict future vulnerability to side effects
31. Risk factors for neuroleptic-induced movement disorders
32. Neuroleptic plasma levels
33. Treatment of neuroleptic-induced akathisia with the 5-HT2 antagonist mianserin. Double-blind, placebo-controlled study
34. A double-blind comparison of clonazepam and placebo in the treatment of neuroleptic-induced akathisia
35. Managing antipsychotic-induced acute and chronic akathisia